Overview

Medications After Adolescent Bariatric Surgery

Status:
Not yet recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

This study will assess the feasibility to assess practicality of early weight loss medication usage in adolescent patients post-VSG with inadequate weight loss. Participants who enroll in the study will be prescribed off-label use of weight loss medications for a period of up to 1 year.

Phase:

Phase 2

Details

Lead Sponsor:

Janey Pratt

Collaborator:

Maternal and Child Health Research Institute

Treatments:

Phentermine
Topiramate